ZA958963B - Steroids with a 17-spiromethylene lactone or lactol group - Google Patents

Steroids with a 17-spiromethylene lactone or lactol group

Info

Publication number
ZA958963B
ZA958963B ZA958963A ZA958963A ZA958963B ZA 958963 B ZA958963 B ZA 958963B ZA 958963 A ZA958963 A ZA 958963A ZA 958963 A ZA958963 A ZA 958963A ZA 958963 B ZA958963 B ZA 958963B
Authority
ZA
South Africa
Prior art keywords
halogen
alkyl
optionally substituted
group
steroids
Prior art date
Application number
ZA958963A
Other languages
English (en)
Inventor
Johannes Antonius Mar Hamersma
Jaap Van Der Louw
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of ZA958963B publication Critical patent/ZA958963B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J19/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 by a lactone ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0092—Alkenyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/001—Lactones
    • C07J21/003—Lactones at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0016—Oximes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA958963A 1994-10-27 1995-10-23 Steroids with a 17-spiromethylene lactone or lactol group ZA958963B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP94203117 1994-10-27

Publications (1)

Publication Number Publication Date
ZA958963B true ZA958963B (en) 1996-05-23

Family

ID=8217314

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA958963A ZA958963B (en) 1994-10-27 1995-10-23 Steroids with a 17-spiromethylene lactone or lactol group

Country Status (26)

Country Link
US (1) US5741786A (https=)
EP (1) EP0709394B1 (https=)
JP (1) JPH08225590A (https=)
KR (1) KR100402636B1 (https=)
CN (1) CN1052237C (https=)
AT (1) ATE199015T1 (https=)
AU (1) AU689642B2 (https=)
BR (1) BR9504576A (https=)
CA (1) CA2161490A1 (https=)
CZ (1) CZ287346B6 (https=)
DE (1) DE69520022T2 (https=)
DK (1) DK0709394T3 (https=)
ES (1) ES2157290T3 (https=)
FI (1) FI113542B (https=)
GR (1) GR3035713T3 (https=)
HU (1) HU221192B1 (https=)
IL (1) IL115659A (https=)
NO (1) NO305252B1 (https=)
NZ (1) NZ280325A (https=)
PL (1) PL187083B1 (https=)
PT (1) PT709394E (https=)
RU (1) RU2168516C2 (https=)
SG (1) SG33569A1 (https=)
TR (1) TR199501327A2 (https=)
TW (1) TW339337B (https=)
ZA (1) ZA958963B (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6407082B1 (en) * 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
US6511970B1 (en) 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
US6034074A (en) 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
US6028064A (en) 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
DE19651000A1 (de) * 1996-12-01 1998-06-04 Schering Ag Oxyiminopregnancarbolactone
AU4093799A (en) 1998-05-22 1999-12-13 Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
US6043235A (en) * 1999-07-21 2000-03-28 Research Triangle Institute 11β-aryl-17, 17-spirothiolane-substituted steroids
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
AU2002322720B2 (en) 2001-07-25 2008-11-13 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
CA2789262C (en) 2005-04-28 2016-10-04 Proteus Digital Health, Inc. Pharma-informatics system
EP1945240B1 (en) 2005-09-16 2016-12-28 Raptor Pharmaceutical Inc Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereof
TR201908314T4 (tr) 2009-02-20 2019-06-21 2 Bbb Medicines B V Glutatyon bazlı ilaç dağıtım sistemi.
KR101909711B1 (ko) 2009-05-06 2018-12-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
WO2021198467A1 (en) * 2020-04-03 2021-10-07 Rockwool International A/S Method of draining water

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2875199A (en) * 1958-04-22 1959-02-24 Searle & Co Lactones of 17-carboxyalkylated estra-1, 3, 5(10)-triene-3, 17-diols and 3-ethers
US3547912A (en) * 1968-07-29 1970-12-15 American Home Prod Derivatives of 2h-pyran-3(6h)-ones and preparation thereof
US3764596A (en) * 1971-06-22 1973-10-09 Sandoz Ag 17-dihydrofuranyl-substituted steroids
DE3306554A1 (de) * 1983-02-22 1984-08-23 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur herstellung von 3-((delta)(pfeil hoch)4(pfeil hoch)-3-ketosteroid-17(alpha)-yl)-propionsaeurelactonen
DE3347510A1 (de) * 1983-12-27 1985-08-01 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur herstellung von 3-oxo-17(alpha)-pregna-4,6-dien-21,17-carbolactonen
FR2596395B1 (fr) * 1986-03-26 1989-05-26 Roussel Uclaf Nouveaux steroides comportant un cycle spirannique en position 17, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
ES2053714T3 (es) * 1987-12-12 1994-08-01 Akzo Nv Proceso para la preparacion de 11-arilesteroides.
FR2688004A1 (fr) * 1992-02-27 1993-09-03 Roussel Uclaf Nouveaux sterouides comportant en position 17 un radical methylene lactone, leur procede et des intermediaires de preparation, leur application comme medicaments.

Also Published As

Publication number Publication date
PT709394E (pt) 2001-06-29
CA2161490A1 (en) 1996-04-28
NO305252B1 (no) 1999-04-26
ATE199015T1 (de) 2001-02-15
GR3035713T3 (en) 2001-07-31
EP0709394B1 (en) 2001-01-31
KR100402636B1 (ko) 2004-02-05
IL115659A (en) 2000-06-01
HU221192B1 (en) 2002-08-28
DE69520022D1 (de) 2001-03-08
PL187083B1 (pl) 2004-05-31
RU2168516C2 (ru) 2001-06-10
KR960014152A (ko) 1996-05-22
FI955108L (fi) 1996-04-28
SG33569A1 (en) 1996-10-18
EP0709394A2 (en) 1996-05-01
NO954293D0 (no) 1995-10-26
IL115659A0 (en) 1996-01-19
PL311135A1 (en) 1996-04-29
DE69520022T2 (de) 2001-06-13
NZ280325A (en) 1997-03-24
EP0709394A3 (en) 1996-09-18
AU3445795A (en) 1996-05-09
TR199501327A3 (https=) 1996-06-21
AU689642B2 (en) 1998-04-02
BR9504576A (pt) 1997-05-20
US5741786A (en) 1998-04-21
CN1131158A (zh) 1996-09-18
TR199501327A2 (tr) 1996-06-21
FI955108A0 (fi) 1995-10-26
HU9503068D0 (en) 1995-12-28
HUT73482A (en) 1996-08-28
CZ275595A3 (en) 1996-05-15
JPH08225590A (ja) 1996-09-03
FI113542B (fi) 2004-05-14
DK0709394T3 (da) 2001-06-18
ES2157290T3 (es) 2001-08-16
CZ287346B6 (en) 2000-10-11
CN1052237C (zh) 2000-05-10
TW339337B (en) 1998-09-01
NO954293L (no) 1996-04-29

Similar Documents

Publication Publication Date Title
GR3035713T3 (en) Steroids with a 17-spiromethylene lactone or lactol group
CA2152819A1 (en) New antiparasitic agents related to the milbemycins and avermectins
AU3009392A (en) 17-spirofuran-3'-ylidene steroids
IL112021A0 (en) Pharmaceutical compositions containing 1,2,3,4,4a,5,10,10a-octahydro-benzo-[g] quinoline derivatives for the prevention or delay of progressive atrophy of the optic nerve
YU49025B (sh) Novi derivati 17,20-epoksi pregnana, njihova primena u dobijanju kortizonskih derivata i intermedijera
PT955286E (pt) Derivados do di-hidro ou tetra-hidronaftaleno tendo uma actividade (ani-)estrogenica
NZ208996A (en) 5-substituted(1,2,4 triazpyrimidin-2-amine derivatives and pharmaceutical compositions
IL117497A0 (en) 17-Difluoromethylene estratriene derivatives and pharmaceutical compositions containing the same
DE3663258D1 (en) Aqueous crystalline suspensions of glycolic-acid esters of steroids
IE861677L (en) 11-methylene-15-ene steroids
TW345487B (en) Composition for controlling noxious insects and/or mites comprising an ester compound
DK164873C (da) 3-keto-17alfa-mercapto-17beta-(substitueret thio)-androstenderivater med anvendelse som mellemprodukter ved fremstillingen af 17,17-bis(substitueret thio)-3-ketoandrostener samt fremgangsmaade til deres fremstilling